肿瘤科指南

订阅

MedSci主页 / 所有栏目 / 肿瘤科指南

2021 ESMO/EURACAN/GENTURIS临床实践指南：骨肉瘤的诊断，治疗和随访

2021-09-01 欧洲肿瘤内科学会 Annals of Oncology

骨肉瘤

2021年9月，欧洲肿瘤内科学会(ESMO)发布了骨肉瘤的诊断，治疗和随访指南。指南针对骨肉瘤的管理提供关键指导建议，涉及诊断，治疗以及随访的相关内容。

中文标题：

2021 ESMO/EURACAN/GENTURIS临床实践指南：骨肉瘤的诊断，治疗和随访

英文标题：

Bone sarcomas: ESMO-EURACAN-GENTURIS-ERNPaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up

发布机构：

欧洲肿瘤内科学会

发布日期：

2021-09-01

简要介绍：

2021年9月，欧洲肿瘤内科学会(ESMO)发布了骨肉瘤的诊断，治疗和随访指南。指南针对骨肉瘤的管理提供关键指导建议，涉及诊断，治疗以及随访的相关内容。

相关资料下载：
[AttachmentFileName(sort=1, fileName=PIIS0923753421042800.pdf)] GetToolGuiderByIdResponse(projectId=1, id=13d851c002186386, title=2021 ESMO/EURACAN/GENTURIS临床实践指南：骨肉瘤的诊断，治疗和随访, enTitle=Bone sarcomas: ESMO-EURACAN-GENTURIS-ERNPaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up, guiderFrom=Annals of Oncology, authorId=0, author=, summary=2021年9月，欧洲肿瘤内科学会(ESMO)发布了骨肉瘤的诊断，治疗和随访指南。指南针对骨肉瘤的管理提供关键指导建议，涉及诊断，治疗以及随访的相关内容。, cover=https://img.medsci.cn/2021914/1631624466224_5579292.jpg, journalId=0, articlesId=null, associationId=14, associationName=欧洲肿瘤内科学会, associationIntro=欧洲肿瘤内科学会（ESMO，European Society for Medical Oncology )是1975年成立的非盈利组织，是欧洲领先的专业组织，致力于提高肿瘤内科的专业性，推进癌症治疗和护理的多学科诊疗方法。, copyright=0, guiderPublishedTime=Wed Sep 01 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #373737;">2021年9月，欧洲肿瘤内科学会(ESMO)发布了骨肉瘤的诊断，治疗和随访指南。指南针对骨肉瘤的管理提供关键指导建议，涉及诊断，治疗以及随访的相关内容。</span></p>, tagList=[TagDto(tagId=1496, tagName=骨肉瘤)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=1496, guiderKeyword=骨肉瘤, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4034, appHits=164, showAppHits=0, pcHits=870, showPcHits=3870, likes=0, shares=13, comments=3, approvalStatus=1, publishedTime=Wed Sep 15 20:45:03 CST 2021, publishedTimeString=2021-09-01, pcVisible=1, appVisible=1, editorId=5579292, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=FUNNYMAN, createdTime=Tue Sep 14 21:02:26 CST 2021, updatedBy=5579292, updatedName=FUNNYMAN, updatedTime=Sat Jan 06 18:52:55 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=PIIS0923753421042800.pdf)])
PIIS0923753421042800.pdf
下载请点击：
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2114533, encodeId=fd332114533ee, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=adfd8538247, createdName=ms1000001510177392, createdTime=Tue Feb 14 08:23:34 CST 2023, time=2023-02-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1234450, encodeId=21b012344509c, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43ff5192496, createdName=1471d48dm72暂无昵称, createdTime=Sun Jul 24 17:49:55 CST 2022, time=2022-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1206131, encodeId=fe01120613117, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9276469151, createdName=ms6000002040131317, createdTime=Sat Mar 26 16:11:34 CST 2022, time=2022-03-26, status=1, ipAttribution=)]
    2023-02-14 ms1000001510177392 来自广东省

    学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2114533, encodeId=fd332114533ee, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=adfd8538247, createdName=ms1000001510177392, createdTime=Tue Feb 14 08:23:34 CST 2023, time=2023-02-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1234450, encodeId=21b012344509c, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43ff5192496, createdName=1471d48dm72暂无昵称, createdTime=Sun Jul 24 17:49:55 CST 2022, time=2022-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1206131, encodeId=fe01120613117, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9276469151, createdName=ms6000002040131317, createdTime=Sat Mar 26 16:11:34 CST 2022, time=2022-03-26, status=1, ipAttribution=)]
    2022-07-24 1471d48dm72暂无昵称

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2114533, encodeId=fd332114533ee, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=adfd8538247, createdName=ms1000001510177392, createdTime=Tue Feb 14 08:23:34 CST 2023, time=2023-02-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1234450, encodeId=21b012344509c, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43ff5192496, createdName=1471d48dm72暂无昵称, createdTime=Sun Jul 24 17:49:55 CST 2022, time=2022-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1206131, encodeId=fe01120613117, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9276469151, createdName=ms6000002040131317, createdTime=Sat Mar 26 16:11:34 CST 2022, time=2022-03-26, status=1, ipAttribution=)]
    2022-03-26 ms6000002040131317

    学习

    0

相关指南

儿童及青少年骨肉瘤诊疗规范（2019版）

中华人民共和国国家卫生健康委员会 · 2019-09-05

2018 ESMO/EURACAN临床实践指南：骨肉瘤的诊断，治疗和随访

欧洲肿瘤内科学会(ESMO,European Society for Medical Oncology) · 2018-10-01

2015 英国骨肉瘤管理指南

暂未更新 · 2016-05-04

2014 ESMO临床实践指南：骨肉瘤的诊断，治疗和随访

欧洲肿瘤内科学会(ESMO,European Society for Medical Oncology) · 2014-09-25

2012 经典型骨肉瘤临床诊疗专家共识

中国临床肿瘤学会骨肉瘤专家委员会 · 2012-10-31

2012 ESMO临床实践指南：骨肉瘤的诊治与随访

欧洲肿瘤内科学会(ESMO,European Society for Medical Oncology) · 2012-06-01

拓展阅读

2012 ESMO临床实践指南：骨肉瘤的诊治与随访

欧洲肿瘤内科学会(ESMO,European Society for Medical Oncology) · 2012-06-01

2012 经典型骨肉瘤临床诊疗专家共识

中国临床肿瘤学会骨肉瘤专家委员会 · 2012-10-31

2014 ESMO临床实践指南：骨肉瘤的诊断，治疗和随访

欧洲肿瘤内科学会(ESMO,European Society for Medical Oncology) · 2014-09-25

2015 英国骨肉瘤管理指南

暂未更新 · 2016-05-04

2018 ESMO/EURACAN临床实践指南：骨肉瘤的诊断，治疗和随访

欧洲肿瘤内科学会(ESMO,European Society for Medical Oncology) · 2018-10-01

儿童及青少年骨肉瘤诊疗规范（2019版）

中华人民共和国国家卫生健康委员会 · 2019-09-05